GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Health Advance HADV · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

-27.00%

Close of 5 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

—

FY2015FY2026

Net income

−$87,213

FY2015FY2026

Free cash flow

−$56,191

FY2015FY2026

Shareholders' equity

−$183,574

FY2015FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Revenue————$6,509$20,000$10,000———
Gross profit————$6,509$20,000————
Operating income−$65,414−$52,733−$47,570−$266,340−$126,319−$21,930$2,200−$29,503−$67,300−$71,871
Net income−$87,213−$54,307−$49,022−$269,653−$130,659$16,947$21,700−$29,503−$67,551−$72,080
Diluted earnings per share-0.00-0.00-0.00-0.00-0.000.000.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Total assets$504,515$500,336$501,279$509,377$308,862$214,298$191,900———
Cash and short-term investments$1,282−$655$287$8,385$1,598$2,649$200———
Total liabilities$688,090$596,696$543,263$502,339$282,170$56,946$51,500$159,395$129,892$105,341
Debt$357,449$297,078$272,028$268,474$238,449$39,613$1,900$98,542$72,774$28
Shareholders' equity−$183,574−$96,360−$41,983$7,038$26,693$157,351$140,400−$159,395−$129,892−$105,341
Shares outstanding1,277m1,159m455m186m186m161m161m126m25m25m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Cash from operations−$56,191−$26,118−$11,652−$273,236−$196,764−$35,315—−$25,768−$38,611−$31,291
Capital spending———−$3−$4−$4————
Free cash flow−$56,191−$26,118−$11,652−$273,239−$196,768−$35,319—−$25,768−$38,611−$31,291

Latest quarters

By quarter end

Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
Operating income−$30,119−$10,810−$13,998−$10,486−$13,838−$10,537−$17,344−$10,270
Net income−$50,308−$11,351−$14,637−$10,917−$13,907−$11,102−$17,716−$11,605
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$504,515$503,747$503,769$499,876$500,336$500,406$500,675$500,836
Cash and short-term investments$1,282−$1,209−$1,187−$1,115−$655−$585−$316−$155
Debt$79,925$68,889$55,433$47,880$43,007$39,040$34,754$24,956
Shareholders' equity−$183,574−$140,811−$121,940−$107,303−$96,360−$82,478−$71,375−$53,658

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-37.4%24.4%-2.7%
Net income-31.4%—0.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-5.9-3.2-0.8-0.1-0.00.40.1
Price to sales————0.80.30.1

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return122%74%100%-46%1422%16065%15020%937%-85%9451%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-for-1 split · 15 Feb 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.